Dexcom – Project Completion

We are pleased to mark the completion of the Dexcom Medical Devices Facility, a state of the art manufacturing and office development delivered over a 25-month programme.

The facility includes a highly technical production environment with cleanrooms, supporting laboratory and engineering spaces, alongside a four-storey office building. As Dexcom’s first manufacturing facility outside of the United States, the project represents a significant milestone for the company’s global expansion. Once operational, it will develop and manufacture real time continuous glucose monitoring systems, supporting diabetes management, and improving patient outcomes globally.

This project was particularly important to our team, reflecting our capability in delivering complex, high specification life sciences facilities, with a strong focus on quality, safety, and programme certainty.

From a sustainability perspective, the project excavated and successfully retained 170,000m³ of subsoil and topsoil, planted 600 native Irish Oak trees as part of the Athenry Tidy Towns initiative, and is submitting for LEED Gold certification. A strong local supply chain was also central to the success of the project, supporting both delivery and the wider regional economy.

Dexcom has been a valued client throughout, and we appreciate the trust placed in us to deliver this significant investment. We would like to thank the design team, our project partners and the wider site team for their commitment and professionalism in bringing this project to completion.